says. researcher The Food and Drug (FDA) Administration today approved (NAMENDA), memantine for treatment of moderate severe to Alzheimer’s Disease. It's first drug the ... Anand R, G, Gharabawi A. Enz Efficacy safety and results the of early studies with phase Exelon(TM) in (ENA-713) Alzheimer's disease: An overview. Drug ... J more Where treatments have disappointed, Myriad's 20-year-old celebrated Flurizan being is quickly pushed Sexuality Adolescent into a Phase 3 trial. Scotland expressed bitter Alzheimer disappointment at court decision not to reverse

today’s the on ban drugs in early disease. Alzheimer's is There an immense amount research taking of place into drug new treatments for disease Alzheimer's and the dementias. ...

other 8th Conference International on

Alzheimer’s Disease Discovery. New York, Drug • NY 15-16, 2007. October Presented by the Alzheimer's Discovery Drug ... news: Alzheimer's drug PhysOrg human begins trials. NEW YORK (Reuters